Literature DB >> 15582544

Amniotic fluid and placental stem cells.

Dario Fauza1.   

Abstract

The amniotic fluid and the placenta are unique sources of different populations of stem cells--mesenchymal, hematopoietic, trophoblastic--and, possibly, of more primitive stem cells. Although much of the amniotic cavity/fluid and the placenta share a common embryonic origin, the specific origins of the stem cells found in these two compartments remain to be determined. Accordingly, it is not yet known whether all or part of these two stem-cell subsets are actually the same. The multilineage potential of the different stem cell populations from these two sources has begun to be described but still much remains to be learned. Thus, it is not surprising that clinical applications related to the use of these cells have yet to be reported. Nevertheless, fertile experimental work from many different groups has introduced a number of promising novel therapeutic concepts utilizing these cells, such as in tissue engineering, cell transplantation, and gene therapy.

Mesh:

Year:  2004        PMID: 15582544     DOI: 10.1016/j.bpobgyn.2004.07.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  57 in total

1.  Role of hepatocyte growth factor in the immunomodulation potential of amniotic fluid stem cells.

Authors:  Tullia Maraldi; Francesca Beretti; Marianna Guida; Manuela Zavatti; Anto De Pol
Journal:  Stem Cells Transl Med       Date:  2015-04-14       Impact factor: 6.940

2.  Neovascularization in a mouse model via stem cells derived from human fetal amniotic membranes.

Authors:  Hwi Gon Kim; Ook Hwan Choi
Journal:  Heart Vessels       Date:  2010-12-25       Impact factor: 2.037

Review 3.  Umbilical cord cells as a source of cardiovascular tissue engineering.

Authors:  Christian Breymann; Dörthe Schmidt; S P Hoerstrup
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

4.  Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells.

Authors:  J Kim; Y Lee; H Kim; K J Hwang; H C Kwon; S K Kim; D J Cho; S G Kang; J You
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

Review 5.  Stem cells and cell therapies for cystic fibrosis and other lung diseases.

Authors:  Daniel J Weiss
Journal:  Pulm Pharmacol Ther       Date:  2007-12-07       Impact factor: 3.410

6.  Differentiation of human amniotic epithelial cells into corneal epithelial-like cells in vitro.

Authors:  Min Yao; Jian Chen; Xiao-Xi Yang; Xiao-Ling Zhang; Qing-Shan Ji; Qing Zhou; Jin-Tang Xu
Journal:  Int J Ophthalmol       Date:  2013-10-18       Impact factor: 1.779

7.  Preclinical regulatory validation of a 3-stage amniotic mesenchymal stem cell manufacturing protocol.

Authors:  Shaun A Steigman; Myriam Armant; Lucy Bayer-Zwirello; Grace S Kao; Leslie Silberstein; Jerome Ritz; Dario O Fauza
Journal:  J Pediatr Surg       Date:  2008-06       Impact factor: 2.545

Review 8.  CD117(+) amniotic fluid stem cells: state of the art and future perspectives.

Authors:  Mara Cananzi; Paolo De Coppi
Journal:  Organogenesis       Date:  2012-07-01       Impact factor: 2.500

9.  Role of amniotic fluid mesenchymal cells engineered on MgHA/collagen-based scaffold allotransplanted on an experimental animal study of sinus augmentation.

Authors:  Paolo Berardinelli; Luca Valbonetti; Aurelio Muttini; Alessandra Martelli; Renato Peli; Vincenzo Zizzari; Delia Nardinocchi; Michele Podaliri Vulpiani; Stefano Tetè; Barbara Barboni; Adriano Piattelli; Mauro Mattioli
Journal:  Clin Oral Investig       Date:  2012-10-14       Impact factor: 3.573

Review 10.  Stem cells in amniotic fluid as new tools to study human genetic diseases.

Authors:  Nicol Siegel; Margit Rosner; Michaela Hanneder; Alessandro Valli; Markus Hengstschläger
Journal:  Stem Cell Rev       Date:  2007-12       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.